Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe thigh is one of three licensed injection sites for Wegovy (semaglutide), and for many people it becomes the go-to spot once they are comfortable with the technique. Both thighs are suitable, you inject into the outer or front area of the upper thigh, and rotation across sites is recommended to keep the skin healthy. Like all Wegovy injections, this is a prescription-only medicine — a clinician assesses your suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes, and it is explicitly recommended in Wegovy's prescribing information alongside the abdomen and the outer upper arm. The outer and front surface of the upper thigh (roughly the middle third of the thigh, avoiding the inner surface and the area close to the knee) has a reliable layer of subcutaneous (under-the-skin) fat, which is exactly where the pen needs to deposit the medicine. Subcutaneous delivery means the semaglutide is absorbed steadily rather than going straight into a muscle or vein.
For people who find the abdomen uncomfortable, particularly in the early weeks of treatment when the injection site can feel more sensitive, the thigh often feels more accessible and less tender. Some find it easier to see and stabilise the tissue there. If you are curious how the thigh specifically compares to the abdomen as an experience, our page on Wegovy: stomach or thigh walks through both sides of that question.
One practical note: the NHS patient information for semaglutide confirms you should not inject into broken, bruised, tattooed or scarred skin. Check the spot you plan to use each week and shift a couple of centimetres away from any mark that has not fully settled.
Sit or lie in a position where the thigh muscle is relaxed rather than tensed — perching on the edge of a bed works well for most people. Take the Wegovy pen out of the fridge around thirty minutes beforehand; a room-temperature pen tends to be more comfortable than a cold one. Pinch a fold of skin gently between your thumb and first two fingers, place the pen flat against the skin (the pen is designed to inject at ninety degrees), press the button, and hold it in place for about ten seconds after you hear or feel the click. The pen does the needle work for you.
Rotating the site is not optional, it is part of using the medicine correctly. That means moving a few centimetres from last week's spot, swapping thighs, and periodically using the abdomen or arm as well. If you always inject in exactly the same place, lipohypertrophy (a fatty lump under the skin) can develop, which affects absorption. A quick reference for the full sequence is on our guide to the Wegovy injection technique.
Some people find it easier to see what they are doing in the thigh than in the abdomen, particularly if they are new to self-injection. That visibility can reduce anxiety around the shot, which matters, treatment works better when you keep going.
The short answer is that the evidence does not show a meaningful clinical difference in semaglutide's effectiveness based on whether you inject into the thigh, abdomen or upper arm, provided the technique is correct and you are injecting into subcutaneous tissue rather than muscle. You can read a closer look at this question on whether Wegovy works better in the thigh or stomach, where the pharmacokinetic detail is covered.
What does affect how well the medicine works is consistency: taking the dose each week, rotating sites properly, and pairing treatment with the reduced-calorie diet and increased activity that the licence specifies. In the STEP 1 trial (68 weeks, adults with obesity or overweight with a weight-related condition, published in the New England Journal of Medicine) participants on semaglutide 2.4mg achieved an average body-weight reduction of around 15%. That result came from consistent weekly dosing, not from picking a specific site.
There is also a broader question about whether you are on the right treatment altogether. If you are thinking about Wegovy's cost alongside its results, our Wegovy prices page sets out the UK private market context honestly.
Mild reactions at the site (a small red mark, slight itching, or a faint bruise) are common, especially in the first weeks of treatment, and usually settle within a day or two. These are not a reason to stop, but they are worth noting.
Seek prompt medical advice if you notice a hard lump, significant swelling, or warmth and redness that spreads and does not improve. Persistently lumpy skin at a single site is a sign to change your rotation pattern and tell your prescriber, and our guidance on using the wegovy inner thigh area covers which parts of the thigh to avoid to reduce that risk. If you ever notice what seems like an allergic reaction (hives, swelling of the face or throat, difficulty breathing) treat it as an emergency.
The MHRA's Yellow Card scheme lets you report any suspected side effect from your medicine directly, including injection-site reactions. It takes a few minutes and contributes to the national picture of how these medicines perform in real-world use.
If you would like a wider look at how Wegovy fits into treatment options, our weight-loss treatment overview covers the licensed medicines available through a private prescription in the UK. For anything specific to your circumstances, the right conversation is with a prescriber, which brings us to the prompt below.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.